Structural Basis for Understanding Oncogenic P53 Mutations and Designing Rescue Drugs.
Joerger, A.C., Ang, H.C., Fersht, A.R.(2006) Proc Natl Acad Sci U S A 103: 15056
- PubMed: 17015838 
- DOI: 10.1073/pnas.0607286103
- Primary Citation of Related Structures:  
2J1W, 2J1X, 2J1Y, 2J1Z, 2J20, 2J21 - PubMed Abstract: 
The DNA-binding domain of the tumor suppressor p53 is inactivated by mutation in approximately 50% of human cancers. We have solved high-resolution crystal structures of several oncogenic mutants to investigate the structural basis of inactivation and provide information for designing drugs that may rescue inactivated mutants ...